<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: oa--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15685230</article-id><article-id pub-id-type="pmc">2361890</article-id><article-id pub-id-type="pii">6602383</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6602383</article-id><article-categories><subj-group subj-group-type="heading"><subject>Translational Therapeutics</subject></subj-group></article-categories><title-group><article-title>Benzo[<italic>b</italic>]thiophenesulphonamide 1,1-dioxide derivatives inhibit tNOX activity in a redox state-dependent manner</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Enc&#x000ed;o</surname><given-names>I</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Morr&#x000e9;</surname><given-names>D J</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Villar</surname><given-names>R</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Gil</surname><given-names>M J</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mart&#x000ed;nez-Merino</surname><given-names>V</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Health Sciences, Universidad P&#x000fa;blica de Navarra, Avda. Bara&#x000f1;ain, 31008 Pamplona, Spain</aff><aff id="aff2"><label>2</label>Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA</aff><aff id="aff3"><label>3</label>Department of Applied Chemistry, Universidad P&#x000fa;blica de Navarra, Campus Arrosad&#x000ed;a, 31006 Pamplona, Spain</aff><author-notes><corresp id="caf1"><label>*</label>Author for correspondence: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:merino@unavarra.es">merino@unavarra.es</email></corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>02</month><year>2005</year></pub-date><pub-date pub-type="collection"><day>22</day><month>02</month><year>2005</year></pub-date><pub-date pub-type="ppub"><day>28</day><month>02</month><year>2005</year></pub-date><volume>92</volume><issue>4</issue><fpage>690</fpage><lpage>695</lpage><history><date date-type="received"><day>26</day><month>07</month><year>2004</year></date><date date-type="rev-recd"><day>09</day><month>12</month><year>2004</year></date><date date-type="accepted"><day>09</day><month>12</month><year>2004</year></date></history><copyright-statement>Copyright 2005, Cancer Research UK</copyright-statement><copyright-year>2005</copyright-year><permissions><copyright-holder>Cancer Research UK</copyright-holder></permissions><abstract><p>Benzo[<italic>b</italic>]thiophenesulphonamide 1,1-dioxide (BTS) derivatives are strong cytotoxic agents that induce reactive oxygen species (ROS) overproduction and apoptosis in tumour cells. Although the precise origin of BTS-induced ROS is not known, a clear correlation between their cytotoxic effect and ability to inhibit a tumour-associated NADH oxidase (tNOX) activity of the plasma membrane has been described. To analyse the putative implication of tNOX in BTS-induced ROS generation, in this work we have synthesised and tested a new BTS derivative, the 6-[<italic>N</italic>-(2-phenylethyl)]benzo[<italic>b</italic>]thiophenesulphonamide 1,1-dioxide. According to its high lipophilicity, this compound showed a strong cytotoxic activity against a panel of six human tumour cell lines, including two human leukaemia (K-562 and CCRF-CEM) and four human solid tumours (HT-29, HTB54, HeLa and MEL-AC). We also tested the ability of this compound to inhibit the tNOX activity and we found an absolute dependence of this inhibition on the redox state of the tNOX: while under reducing conditions, that is, 100&#x02009;m<sc>M</sc> GSH, the drug inhibits strongly the NOX activity with an EC<sub>50</sub> of about 0.1&#x02009;n<sc>M</sc>, under oxidising conditions, there is no effect of the drug or just a slight stimulation of activity.</p></abstract><kwd-group><kwd>benzo[<italic>b</italic>]thiophenesulphonamides</kwd><kwd>antineoplasic drugs</kwd><kwd>ECTO-NOX</kwd><kwd>tumour-associated NADH oxidase</kwd><kwd>redox state</kwd></kwd-group></article-meta></front><body><p>Benzo[<italic>b</italic>]thiophenesulphonamide 1,1-dioxide (BTS) derivatives have been reported as a new class of potential antineoplastic agents (<xref ref-type="other" rid="bib17">Mart&#x000ed;nez-Merino <italic>et al</italic>, 2000</xref>). These compounds, which were synthesised and analysed in <italic>in vitro</italic> antitumour assays on the basis of theoretic structure&#x02013;activity COMFA studies of sulphonylureas (<xref ref-type="other" rid="bib18">Mart&#x000ed;nez-Merino <italic>et al</italic>, 1995</xref>; <xref ref-type="other" rid="bib12">Gil <italic>et al</italic>, 1999</xref>), induce in human leukaemia CCRF-CEM cells a typical process of apoptosis that includes cell shrinkage, phosphatidylserine translocation to the cell surface, mitochondrial dysfunction, caspase activation, chromatin condensation and internucleosomal DNA degradation (<xref ref-type="other" rid="bib4">Alonso <italic>et al</italic>, 2003</xref>). CCRF-CEM cells start to accumulate reactive oxygen species (ROS) within minutes after BTS addition, and these molecules are essential mediators required for the induction of cytochrome 3 mitochondrial release, caspase-3 activation and cell death, as revealed by the fact that these events are prevented by treatment with <italic>N</italic>-acetyl-cysteine (<xref ref-type="other" rid="bib4">Alonso <italic>et al</italic>, 2003</xref>). Although the precise origin of BTS-induced ROS is not known, a clear correlation between their cytotoxic effect and ability to inhibit an NADH oxidase (NOX) activity found in the plasma membrane and conditioned culture medium of CCRF-CEM cells has been described (<xref ref-type="other" rid="bib5">Alonso <italic>et al</italic>, 2001</xref>).</p><p>ECTO-NOX are cell surface-associated and growth-related protein oxidases that exhibit two different activities, protein disulphide-thiol interchange and hydroquinone (or NADH) oxidation, that alternate to yield oscillatory patterns (<xref ref-type="other" rid="bib26">Morr&#x000e9; and Morr&#x000e9;, 2003</xref>). Two forms of ECTO-NOX have been detected in sera of cancer patients (<xref ref-type="other" rid="bib36">Wang <italic>et al</italic>, 2003</xref>): a widely distributed constitutive NOX (CNOX) of the mammalian cell surface that has a period length of 24&#x02009;min (<xref ref-type="other" rid="bib32">Sedlak <italic>et al</italic>, 2001</xref>) and is resistant to inhibition by quinone site inhibitors (<xref ref-type="other" rid="bib9">Chueh <italic>et al</italic>, 2002a</xref>) like the vainilloid capsaicin or the antitumour sulphonylurea <italic>N</italic>-4-(methylphenylsulphonyl)-<italic>N</italic>&#x02032;-(4-chlorophenyl)urea (LY181984), and a tumour-associated NOX (tNOX) with a period length of 22&#x02009;min (<xref ref-type="other" rid="bib9">Chueh <italic>et al</italic>, 2002a</xref>) that is inhibited by capsaicin (<xref ref-type="other" rid="bib23">Morr&#x000e9; <italic>et al</italic>, 1997a</xref>) or LY181984 (<xref ref-type="other" rid="bib28">Morr&#x000e9; and Reust, 1997b</xref>) and is low or absent from sera of individuals not diagnosed as having cancer (<xref ref-type="other" rid="bib23">Morr&#x000e9; <italic>et al</italic>, 1997a</xref>). The tNOX protein is also specifically inhibited in HeLa and human mammary adenocarcinoma cells by (&#x02212;)-epigallocatechin-3-gallate (EGCg) (<xref ref-type="other" rid="bib22">Morr&#x000e9; <italic>et al</italic>, 2000</xref>), the principal catechin of green tea; EGCg also inhibited growth of transformed cells in culture. Since this action appears to result from an effect on regulation of cell cycle progression and induction of apoptosis (<xref ref-type="other" rid="bib2">Ahmad <italic>et al</italic>, 1997</xref>, <xref ref-type="other" rid="bib3">2000</xref>, <xref ref-type="other" rid="bib1">2002</xref>; <xref ref-type="other" rid="bib13">Gupta <italic>et al</italic>, 2000</xref>) rather than from an unspecific antioxidant function (<xref ref-type="other" rid="bib31">Salucci <italic>et al</italic>, 2002</xref>), tNOX protein has been proposed as the molecular target on cancer cells to explain their specific inhibition of growth by EGCg (<xref ref-type="other" rid="bib22">Morr&#x000e9; <italic>et al</italic>, 2000</xref>).</p><p>The putative implication of tNOX in BTS-induced ROS generation and the fact that some enzymes related with ROS control such as the glutathione reductase and the glutathione <italic>S</italic>-transferase present a hydrophobic pocket near their active site (<xref ref-type="other" rid="bib15">Karplus and Schulz, 1989</xref>; <xref ref-type="other" rid="bib8">Chern <italic>et al</italic>, 2000</xref>) led us to synthesise and analyse new derivatives of the benzo[<italic>b</italic>]thiophene 1,1-dioxide carrying hydrophobic substituents of different length and grade of flexibility on the sulphonamide group and, in some cases, a clear correlation between the lipophilicity (log&#x02009;<italic>P</italic>) and the cytotoxic effect of these compounds was observed (<xref ref-type="other" rid="bib35">Villar <italic>et al</italic>, 2004</xref>). Here we describe the synthesis and cytotoxic activity of 6-[<italic>N</italic>-(2-phenylethyl)]benzo[<italic>b</italic>]thiophenesulphonamide 1,1-dioxide (BTS-2), a new BTS derivative with increased flexibility, high lipophilicity (log&#x02009;<italic>P</italic>=2.82) and a predicted low toxicity for its putative metabolites, and we show its ability to specifically inhibit the tNOX activity and the absolute dependence of this inhibition on the redox state of the tNOX.</p><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Chemistry</title><p>Benzo[<italic>b</italic>]thiophenesulphonamide 1,1-dioxide (BTS-1) was prepared as previously described (<xref ref-type="other" rid="bib17">Mart&#x000ed;nez-Merino <italic>et al</italic>, 2000</xref>).</p><p>The synthesis of BTS-2 was carried out by the usual methods described for the synthesis of sulphonamide derivatives (<xref ref-type="other" rid="bib35">Villar <italic>et al</italic>, 2004</xref>), that is, through the treatment of the sulphonyl chloride derivative with ammonia or amines (<xref ref-type="fig" rid="fig1">Scheme 1</xref>). The chlorosulphonyl derivative was obtained from the 6-aminobenzo[<italic>b</italic>]thiophene 1,1-dioxide by the Meerwein's method (<xref ref-type="other" rid="bib19">Meerwein <italic>et al</italic>, 1957</xref>) (treatment of diazonium salts with sulphonyl chloride in the presence of cuprous chloride), and then treated with phenetylamine to give the BTS-2 (28.1&#x00025; yield). The previous amine derivative was produced by reduction of 6-nitrobenzo[<italic>b</italic>]thiophene 1,1-dioxide, and the last one was synthesised according to procedures previously published (<xref ref-type="other" rid="bib7">Challenger and Clapham, 1948</xref>) (60&#x00025; yield). The oxidation of benzo[<italic>b</italic>]thiophene was carried out with 30&#x00025; hydrogen peroxide.</p></sec><sec><title>Cell culture</title><p>American Type Culture Collection (ATCC, Manassas, VA) or European Collection of Cell Cultures (ECACC, Porton Down, Salisbury, UK) provided human tumour cell lines. Six cell lines were used: two human leukaemia (K-562 and CCRF-CEM) and four human solid tumours, one colon carcinoma (HT-29), one lung carcinoma (HTB54), one cervix epitheloid carcinoma (HeLa) and one melanoma (MEL-AC). MEL-AC cells were kindly provided by Dr Natalia L&#x000f3;pez-Moratalla (Universidad de Navarra, Pamplona, Spain). Human lung fibroblasts (HLFs) were kindly provided by Dr Markus Nabholzs (ISREC, Epalinges, Switzerland). Cells were grown in RPMI 1640 medium (Life Technologies, Barcelona, Spain) supplemented with 10&#x00025; fetal calf serum, 2&#x02009;m<sc>M L</sc>-glutamine, 100&#x02009;U&#x02009;ml<sup>&#x02212;1</sup> penicillin, 100&#x02009;<italic>&#x003bc;</italic>g&#x02009;ml<sup>&#x02212;1</sup> streptomycin and 10&#x02009;m<sc>M</sc> HEPES buffer (pH 7.4).</p></sec><sec><title>Cytotoxicity assay</title><p>The cytotoxic effect of each substance was tested at five different doses between 0.01 and 100&#x02009;<italic>&#x003bc;</italic><sc>M</sc>. Each substance was initially dissolved in DMSO at a concentration of 0.1&#x02009;<sc>M</sc>, and serial dilutions were prepared using culture medium. The plates with cells from the different lines, to which media containing the substance under test were added, were incubated for 72&#x02009;h at 37&#x000b0;C in a humidified atmosphere containing 5&#x00025; CO<sub>2</sub>. Cytotoxicity was then determined by a colorimetric microassay based on the use of MTT (<xref ref-type="other" rid="bib30">Mosmann, 1983</xref>). Results are expressed as GI<sub>50</sub>, concentration that reduced by 50&#x00025; the growth of treated cells with respect to untreated controls.</p></sec><sec><title>Protein isolation and determination</title><p>Cell membrane NOX activity (Cellex) was released in soluble form from HeLa cells (whole cells) as previously described (<xref ref-type="other" rid="bib11">Del Castillo-Olivares <italic>et al</italic>, 1998</xref>).</p><p>Proteins were determined by the bicinchoninic acid/copper assay (<xref ref-type="other" rid="bib33">Smith <italic>et al</italic>, 1985</xref>) obtained from Pierce using bovine serum albumin as standard.</p></sec><sec><title>NADH oxidase activity measurement</title><p>NADH oxidase activity was determined as the disappearance of NADH at 340&#x02009;nm in a reaction mixture containing 25&#x02009;m<sc>M</sc> Tris-Mes buffer (pH 7.2), 1&#x02009;m<sc>M</sc> KCN to inhibit any potential mitochondrial oxidase activity and 150&#x02009;<italic>&#x003bc;</italic><sc>M</sc> NADH at 37&#x000b0;C and continuous stirring (<xref ref-type="other" rid="bib36">Wang <italic>et al</italic>, 2003</xref>). Assays were initiated by addition of NADH. Absorbance was recorded for 1&#x02009;min after adding NADH and a millimolar extinction coefficient of 6.22 was used to determine specific activity.</p></sec></sec><sec><title>RESULTS</title><p>The cytotoxic activity of BTS-1 and BTS-2 (<xref ref-type="fig" rid="fig2">Figure 1</xref>) was tested against a panel of human tumour cell lines, including cervix epitheloid carcinoma (HeLa), lymphocytic leukaemia (CCRF-CEM), myelocytic leukaemia (K-562), melanoma (MEL-AC), human colon carcinoma (HT-29) and lung carcinoma (HTB-54), and also against normal HLFs growing in culture. Cells were grown in RPMI 1640 medium (Life Technologies) supplemented with 10&#x00025; fetal calf serum, 2&#x02009;m<sc>M L</sc>-glutamine, 100&#x02009;u&#x02009;ml<sup>&#x02212;1</sup> penicillin, 100&#x02009;<italic>&#x003bc;</italic>g&#x02009;ml<sup>&#x02212;1</sup> streptomycin and 10&#x02009;m<sc>M</sc> HEPES buffer (pH 7.4). The cytotoxic effect of each substance was tested at five different doses between 0.01 and 100&#x02009;<italic>&#x003bc;</italic><sc>M</sc>. The plates with cells from the different lines, to which media containing the substance under test were added, were incubated for 3 days and cell survival was then determined by an MTT-based colorimetric assay (<xref ref-type="other" rid="bib30">Mosmann, 1983</xref>). Results are expressed as GI<sub>50</sub>, concentration that reduced by 50&#x00025; the growth of treated cells with respect to untreated controls. As shown in <xref rid="tbl1" ref-type="table">Table 1</xref>, growth of every cell line was clearly affected by the tested compounds, and is worth noting that according to its higher lipophilicity, BTS-2 was more cytotoxic against each one of the tested cell lines than the lead compound (BTS-1). Moreover, activity of BTS-2 was in the same order of magnitude as commercial doxorubicin against K-562 tumour cells and normal lung fibroblasts growing in culture. <xref ref-type="fig" rid="fig3">Figure 2</xref> shows curves with the original data from which the GI<sub>50</sub> values for BTS-1 and BTS-2 were calculated.</p><p>It has been previously shown that BTS-1 and some related diarylsulphonylureas (DSU) are able to inhibit a tumour cell-specific NOX activity present in the membrane of CCRF-CEM cells (<xref ref-type="other" rid="bib5">Alonso <italic>et al</italic>, 2001</xref>). As we had said before, until now tNOX activity is the only cell target proposed to explain the specific inhibition of growth of cancer cells induced by the antitumour sulphonylurea LY181984 (<xref ref-type="other" rid="bib27">Morr&#x000e9; <italic>et al</italic>, 1995a</xref>,&#x02009;<xref ref-type="other" rid="bib20">1995b</xref>) and the green tea catechin EGCg (<xref ref-type="other" rid="bib22">Morr&#x000e9; <italic>et al</italic>, 2000</xref>). Since BTS-2 was designed on the basis of experimental results obtained with BTS-1 and other BTS that are structurally related with DSU, we decided to further analyse the action of BTS-2 on tNOX activity. For these purpose, we performed standard NOX assays using either a preparation released at pH 5 from HeLa cells obtained from Cellex Biosciences (Minneapolis, USA), which is a mixture of NOXs (<xref ref-type="other" rid="bib11">Del Castillo-Olivares <italic>et al</italic>, 1998</xref>), or from intact HeLa cells. NADH is an impermeant substrate and, therefore, can be used to measure cell surface NADH activity with whole cells. Results with isolated plasma membrane and with whole cells were similar. NADH oxidase activity was determined as the disappearance of NADH measured at 340&#x02009;nm. The compound was dissolved in ethanol and compared to solvent alone. As shown in <xref ref-type="fig" rid="fig4">Figure 3</xref>, in the presence of reducing conditions, that is, 100&#x02009;<italic>&#x003bc;</italic><sc>M</sc> GSH, the drug inhibited strongly the NOX activity of both the intact HeLa (<xref ref-type="fig" rid="fig4">Figure 3A</xref>) and Cellex (<xref ref-type="fig" rid="fig4">Figure 3B</xref>) preparations with an EC<sub>50</sub> of about 0.1&#x02009;n<sc>M</sc>. The figure also shows small stimulations by ethanol (chemical hormesis) that are not unusual for the cell surface NOX activities (<xref ref-type="other" rid="bib21">Morr&#x000e9;, 2000</xref>). Although both the Cellex and intact HeLa preparations contain a cancer-specific and drug-inhibited tNOX and a constitutive and drug-resistant NOX, the data show that only tNOX is being inhibited, and indicate that this inhibition, which is dose dependent, is almost complete at 0.1&#x02009;<italic>&#x003bc;</italic><sc>M</sc>. Otherwise, the residual NOX activity corresponding to CNOX would approach zero at the high drug concentration. In agreement with this, NOX activities of plasma membranes purified from soybean (<italic>Glycine max</italic>), which contain only CNOX, were unaffected by BTS-2 over the concentration range 10<sup>&#x02212;11</sup>&#x02013;10<sup>&#x02212;5</sup>&#x02009;<sc>M</sc> (<italic>N</italic>=4) (not shown).</p><p>The effect of the drug on the NOX activity under oxidising conditions is analysed in <xref ref-type="fig" rid="fig5">Figure 4</xref>. As can be seen, when the oxidising conditions were provided by treatment of HeLa cells with hydrogen peroxide (<xref ref-type="fig" rid="fig5">Figure 4A</xref>), the derivative inhibited only at the highest concentration of 10&#x02009;<italic>&#x003bc;</italic><sc>M</sc>. Moreover, with Cellex preparations (<xref ref-type="fig" rid="fig5">Figure 4B</xref>), stimulation was recorded at 10&#x02009;<italic>&#x003bc;</italic><sc>M</sc>. As with hydrogen peroxide, when the assays were performed in the presence of 100&#x02009;<italic>&#x003bc;</italic><sc>M</sc> GSSG (<xref ref-type="fig" rid="fig5">Figure 4C and D</xref>), we could see no inhibition of the NOX activity, only a slight stimulation. Thus, it can be concluded that while under reducing conditions BTS-2 strongly inhibits tNOX, under oxidising conditions there is no effect of the drug or just a slight stimulation of activity. The absolute dependency of inhibition on redox state of tNOX has also been described with the antitumour sulphonylureas (<xref ref-type="other" rid="bib29">Morr&#x000e9; <italic>et al</italic>, 1998</xref>).</p></sec><sec><title>DISCUSSION</title><p>We have previously shown that BTS derivatives are strong cytotoxic agents that induce ROS overproduction and apoptosis in tumour cells (<xref ref-type="other" rid="bib4">Alonso <italic>et al</italic>, 2003</xref>). We have also shown that while the BTS derivatives that exhibit this cytotoxic activity are able to inhibit a NOX activity of the plasma membrane of leukaemia CCRF-CEM cells, those that lack cytotoxic activity also lack this inhibitory effect (<xref ref-type="other" rid="bib5">Alonso <italic>et al</italic>, 2001</xref>), thus suggesting that ECTO-NOX proteins could provide a molecular target for the induction of ROS production by BTS derivatives. Here we report that BTS-2, a new BTS derivative with high lipophilicity and improved cytotoxic activity, specifically inhibits the tNOX activity of HeLa cells, and we show that this inhibition is dependent on the redox state of tNOX.</p><p>A number of motifs within tNOX, including an NADH binding site, a quinone binding site and sites for protein disulphide-thiol interchange, account for the range of its functional activities (<xref ref-type="other" rid="bib10">Chueh <italic>et al</italic>, 2002b</xref>). The drug response of tNOX has been studied extensively with LY181984 (<xref ref-type="other" rid="bib29">Morr&#x000e9; <italic>et al</italic>, 1998</xref>). Activity is inhibited or stimulated by this sulphonylurea depending on the redox environment of the protein. Ubiquinone competes with both LY181984 binding and inhibition of enzymatic activities and so the drug, like capsaicin (<xref ref-type="other" rid="bib24">Morr&#x000e9; <italic>et al</italic>, 1995c</xref>), EGCg (<xref ref-type="other" rid="bib22">Morr&#x000e9; <italic>et al</italic>, 2000</xref>) and adriamycin (<xref ref-type="other" rid="bib25">Morr&#x000e9; <italic>et al</italic>, 1997c</xref>), which also inhibit activity, is considered to occupy the quinone binding site. Interestingly, while the normal CNOX isoform and tNOX share functional characteristics, CNOX appears to lack the quinone binding motif EEMTE (<xref ref-type="other" rid="bib9">Chueh <italic>et al</italic>, 2002a</xref>), a fact that could explain why both enzymes differ primarily in their sensitivity to these drugs. Since we show here that under reducing conditions BTS-2 inhibits strongly the NOX activity of both intact HeLa cells and Cellex preparations containing both tNOX and CNOX, while ECTO-NOX activities of plasma membranes from soybean, which contain only CNOX, are unaffected by this drug, the possibility that BTS derivatives exert their specific inhibitory action on tNOX activity through binding to the quinone site should be considered.</p><p>It has been described that the tNOX activity can be inhibited by thiol reagents such as the <italic>N</italic>-ethyl-maleimide (NEM) (<xref ref-type="other" rid="bib27">Morr&#x000e9; <italic>et al</italic>, 1995a</xref>,&#x02009;<xref ref-type="other" rid="bib20">1995b</xref>). It has also been reported that compounds carrying the benzo[<italic>b</italic>]thiophene 1,1-dioxide nucleus, like BTS-1 and -2, are thiol reagents (<xref ref-type="other" rid="bib6">Bordwell <italic>et al</italic>, 1954</xref>). For this reason, it is very interesting that the C2&#x02013;C3 dihydro derivative of BTS-1, which was reported to be inactive both in the cytotoxicity and enzymatic assays (<xref ref-type="other" rid="bib5">Alonso <italic>et al</italic>, 2001</xref>), cannot be considered a thiol reagent. Since this compound and BTS-1 have identical molecular sizes and capacities to interact through polar groups, hydrogen bonds and/or hydrophobic interactions with putative receptor sites, activity of BTS-1 can be attributed to the C2&#x02013;C3 double bond reactivity. In agreement with this, the C3-methyl derivative of BTS-1 shows no cytotoxic activity (<xref ref-type="other" rid="bib35">Villar <italic>et al</italic>, 2004</xref>), a result that can be attributed to its impaired reactivity towards thiol groups. Thus, the possibility that BTS derivatives exert their inhibitory action on tNOX activity by interacting with cysteines of the active sites for protein disulphide-thiol interchange should also be considered. The fact that BTS actions over cell growth are prevented by previous treatment of the cells with <italic>N</italic>-acetyl-cysteine (<xref ref-type="other" rid="bib4">Alonso <italic>et al</italic>, 2003</xref>) and our finding that under oxidising conditions there is no effect of BTS-2 on the tNOX activity also support this idea.</p><p>Interference with DNA and RNA is generally considered to account for the cytotoxicity of anthracycline antitumour drugs. However, it has been shown that doxorubicin is cytotoxic even without entering the cells (<xref ref-type="other" rid="bib34">Tritton and Yee, 1982</xref>), and inhibition of tNOX activity by doxorubicin (EC<sub>50</sub>=0.7&#x02009;n<sc>M</sc>) has been described (<xref ref-type="other" rid="bib25">Morr&#x000e9; <italic>et al</italic>, 1997c</xref>; <xref ref-type="other" rid="bib14">Hedges <italic>et al</italic>, 2003</xref>). Interestingly, when cell growth is inhibited, redox activities of the plasma membrane are also inhibited, and thus NOX activity of the plasma membrane has been suggested as a growth-related doxorubicin target at the surface of cancer cells (<xref ref-type="other" rid="bib16">Kim <italic>et al</italic>, 2002</xref>; <xref ref-type="other" rid="bib14">Hedges <italic>et al</italic>, 2003</xref>). For this reason, the fact that BTS-2 acts in the same order of magnitude as doxorubicin against K-562 tumour cells and also against normal HLFs that should have a low or even absent tNOX activity rises the possibility of additional sites of action for this drug. Further experiments are required to clarify this fact.</p></sec></body><back><ack><p>RV was the recipient of a fellowship from the Departamento de Educaci&#x000f3;n y Cultura, Gobierno de Navarra.</p></ack><ref-list><ref id="bib1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Adhami</surname><given-names>VM</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>P</given-names></name><name><surname>Mukhtar</surname><given-names>H</given-names></name></person-group><article-title>Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate</article-title><source>Arch Biochem Biophys</source><year>2002</year><volume>398</volume><fpage>125</fpage><lpage>131</lpage><!--PubMed citation query: 'Arch Biochem Biophys||398|125||bib1|'--><pub-id pub-id-type="pmid">11811957</pub-id></citation></ref><ref id="bib2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Feyes</surname><given-names>DK</given-names></name><name><surname>Nieminen</surname><given-names>AL</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name><name><surname>Mukhtar</surname><given-names>H</given-names></name></person-group><article-title>Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells</article-title><source>J Natl Cancer Inst</source><year>1997</year><volume>89</volume><fpage>1881</fpage><lpage>1886</lpage><!--PubMed citation query: 'J Natl Cancer Inst||89|1881||bib2|'--><pub-id pub-id-type="pmid">9414176</pub-id></citation></ref><ref id="bib3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Mukhtar</surname><given-names>H</given-names></name></person-group><article-title>Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells <italic>versus</italic> normal cells</article-title><source>Arch Biochem Biophys</source><year>2000</year><volume>376</volume><fpage>338</fpage><lpage>346</lpage><!--PubMed citation query: 'Arch Biochem Biophys||376|338||bib3|'--><pub-id pub-id-type="pmid">10775421</pub-id></citation></ref><ref id="bib4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>MM</given-names></name><name><surname>Asumendi</surname><given-names>A</given-names></name><name><surname>Villar</surname><given-names>J</given-names></name><name><surname>Gil</surname><given-names>MJ</given-names></name><name><surname>Mart&#x000ed;nez-Merino</surname><given-names>V</given-names></name><name><surname>Enc&#x000ed;o</surname><given-names>I</given-names></name><name><surname>Migliaccio</surname><given-names>M</given-names></name></person-group><article-title>New benzo(<italic>b</italic>)thiophenesulphonamide 1,1-dioxide derivatives induce a reactive oxygen species-mediated process of apoptosis in tumor cells</article-title><source>Oncogene</source><year>2003</year><volume>22</volume><fpage>3759</fpage><lpage>3769</lpage><!--PubMed citation query: 'Oncogene||22|3759||bib4|'--><pub-id pub-id-type="pmid">12802283</pub-id></citation></ref><ref id="bib5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>MM</given-names></name><name><surname>Enc&#x000ed;o</surname><given-names>I</given-names></name><name><surname>Mart&#x000ed;nez-Merino</surname><given-names>V</given-names></name><name><surname>Gil</surname><given-names>MJ</given-names></name><name><surname>Migliaccio</surname><given-names>M</given-names></name></person-group><article-title>New cytotoxic benzo(<italic>b</italic>)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumor cells</article-title><source>Br J Cancer</source><year>2001</year><volume>85</volume><fpage>1400</fpage><lpage>1402</lpage><!--PubMed citation query: 'Br J Cancer||85|1400||bib5|'--><pub-id pub-id-type="pmid">11720481</pub-id></citation></ref><ref id="bib6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bordwell</surname><given-names>FG</given-names></name><name><surname>Chapman</surname><given-names>RD</given-names></name><name><surname>McKellin</surname><given-names>WH</given-names></name></person-group><article-title>Benzothiophen chemistry. VI. A peroxide effect in the addition of thiophenols to benzothiophene 1-dioxide</article-title><source>J Am Chem Soc</source><year>1954</year><volume>76</volume><fpage>3637</fpage><lpage>3639</lpage><!--PubMed citation query: 'J Am Chem Soc||76|3637||bib6|'--></citation></ref><ref id="bib7"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Challenger</surname><given-names>F</given-names></name><name><surname>Clapham</surname><given-names>PH</given-names></name></person-group><article-title>Some derivatives of thionaphthen</article-title><source>J Chem Soc</source><year>1948</year><fpage>1615</fpage><lpage>1618</lpage>oct</citation></ref><ref id="bib8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chern</surname><given-names>MK</given-names></name><name><surname>Wu</surname><given-names>TC</given-names></name><name><surname>Hsieh</surname><given-names>CH</given-names></name><name><surname>Chou</surname><given-names>CC</given-names></name><name><surname>Liu</surname><given-names>LF</given-names></name><name><surname>Kuan</surname><given-names>IC</given-names></name><name><surname>Yeh</surname><given-names>YH</given-names></name><name><surname>Hsiao</surname><given-names>CD</given-names></name><name><surname>Ming</surname><given-names>F</given-names></name><name><surname>Tam</surname><given-names>MF</given-names></name></person-group><article-title>Tyr115, gln165 and trp209 contribute to the 1, 2-epoxy-3-(<italic>p</italic>-nitrophenoxy)propane-conjugating activity of glutathione <italic>S</italic>-transferase cGSTM1-1</article-title><source>J Mol Biol</source><year>2000</year><volume>300</volume><fpage>1257</fpage><lpage>1269</lpage><!--PubMed citation query: 'J Mol Biol||300|1257||bib8|'--><pub-id pub-id-type="pmid">10903867</pub-id></citation></ref><ref id="bib9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chueh</surname><given-names>PJ</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Cho</surname><given-names>N</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface</article-title><source>Biochemistry</source><year>2002a</year><volume>41</volume><fpage>3732</fpage><lpage>3741</lpage><!--PubMed citation query: 'Biochemistry||41|3732||bib9|'--><pub-id pub-id-type="pmid">11888291</pub-id></citation></ref><ref id="bib10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chueh</surname><given-names>PJ</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>A site-directed mutagenesis analysis of tNOX functional domains</article-title><source>Biochim Biophys Acta</source><year>2002b</year><volume>1594</volume><fpage>74</fpage><lpage>83</lpage><!--PubMed citation query: 'Biochim Biophys Acta||1594|74||bib10|'--><pub-id pub-id-type="pmid">11825610</pub-id></citation></ref><ref id="bib11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Del Castillo-Olivares</surname><given-names>A</given-names></name><name><surname>Yantiri</surname><given-names>F</given-names></name><name><surname>Chueh</surname><given-names>PJ</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sweeting</surname><given-names>M</given-names></name><name><surname>Sedlak</surname><given-names>D</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Burgess</surname><given-names>J</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells</article-title><source>Arch Biochem Biophys</source><year>1998</year><volume>358</volume><fpage>125</fpage><lpage>140</lpage><!--PubMed citation query: 'Arch Biochem Biophys||358|125||bib11|'--><pub-id pub-id-type="pmid">9750173</pub-id></citation></ref><ref id="bib12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>MJ</given-names></name><name><surname>Ma&#x000f1;&#x000fa;</surname><given-names>M</given-names></name><name><surname>Arteaga</surname><given-names>C</given-names></name><name><surname>Migliaccio</surname><given-names>M</given-names></name><name><surname>Enc&#x000ed;o</surname><given-names>IJ</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>A</given-names></name><name><surname>Mart&#x000ed;nez-Merino</surname><given-names>V</given-names></name></person-group><article-title>Synthesis and cytotoxic activity of <italic>N</italic>-(2-pyridylsulfenyl)urea derivatives. A new class of potential antineoplastic agents</article-title><source>Bioorg Med Chem Lett</source><year>1999</year><volume>9</volume><fpage>2321</fpage><lpage>2324</lpage><!--PubMed citation query: 'Bioorg Med Chem Lett||9|2321||bib12|'--><pub-id pub-id-type="pmid">10476861</pub-id></citation></ref><ref id="bib13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Nieminen</surname><given-names>AL</given-names></name><name><surname>Mukhtar</surname><given-names>H</given-names></name></person-group><article-title>Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells</article-title><source>Toxicol Appl Pharmacol</source><year>2000</year><volume>164</volume><fpage>82</fpage><lpage>90</lpage><!--PubMed citation query: 'Toxicol Appl Pharmacol||164|82||bib13|'--><pub-id pub-id-type="pmid">10739747</pub-id></citation></ref><ref id="bib14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hedges</surname><given-names>KL</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Wub</surname><given-names>LY</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>Adriamycin tolerance in human mesothelioma lines and cell surface NADH oxidase</article-title><source>Life Sci</source><year>2003</year><volume>73</volume><fpage>1189</fpage><lpage>1198</lpage><!--PubMed citation query: 'Life Sci||73|1189||bib14|'--><pub-id pub-id-type="pmid">12818726</pub-id></citation></ref><ref id="bib15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karplus</surname><given-names>PA</given-names></name><name><surname>Schulz</surname><given-names>GE</given-names></name></person-group><article-title>Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2&#x02009;&#x000c5; resolution</article-title><source>J Mol Biol</source><year>1989</year><volume>210</volume><fpage>163</fpage><lpage>180</lpage><!--PubMed citation query: 'J Mol Biol||210|163||bib15|'--><pub-id pub-id-type="pmid">2585516</pub-id></citation></ref><ref id="bib16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Crane</surname><given-names>FL</given-names></name><name><surname>Faulk</surname><given-names>WP</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>Purification and characterization of a doxorubicin-inhibited NADH-quinone (NADH-ferricyanide) reductase from rat liver plasma membranes</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>16441</fpage><lpage>16447</lpage><!--PubMed citation query: 'J Biol Chem||277|16441||bib16|'--><pub-id pub-id-type="pmid">11875069</pub-id></citation></ref><ref id="bib17"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Merino</surname><given-names>V</given-names></name><name><surname>Gil</surname><given-names>MJ</given-names></name><name><surname>Enc&#x000ed;o</surname><given-names>I</given-names></name><name><surname>Migliaccio</surname><given-names>M</given-names></name><name><surname>Arteaga</surname><given-names>C</given-names></name></person-group><article-title>Benzo[<italic>b</italic>]thiophene sulfonamide-1,1-dioxido derivatives and their use as antineoplastic agents</article-title><year>2000</year>WO Patent 00/63202</citation></ref><ref id="bib18"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Merino</surname><given-names>V</given-names></name><name><surname>Mart&#x000ed;nez-Gonz&#x000e1;lez</surname><given-names>A</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>A</given-names></name><name><surname>Gil</surname><given-names>MJ</given-names></name></person-group><article-title>3D-QSAR of the diarylsulphonylureas as antineoplastic agents</article-title><source>QSAR and Molecular Modelling: Concepts, Computational Tools and Biological Applications</source><year>1995</year><publisher-name>Barcelona: Prous Science Publishers</publisher-name><fpage>478</fpage><lpage>480</lpage>Sanz F, Giraldo J, Manaut F (eds) pp</citation></ref><ref id="bib19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meerwein</surname><given-names>H</given-names></name><name><surname>Dittmer</surname><given-names>G</given-names></name><name><surname>Gollner</surname><given-names>R</given-names></name></person-group><article-title>Verfahren zur herstellung aromatischer sulfons&#x000e4;urechloride, eine neue modifikation der Sandmeyerschen reaktion</article-title><source>Chem Ver</source><year>1957</year><volume>90</volume><fpage>841</fpage><lpage>1178</lpage><!--PubMed citation query: 'Chem Ver||90|841||bib19|'--></citation></ref><ref id="bib20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Wu</surname><given-names>LY</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name></person-group><article-title>The antitumor sulfonylurea <italic>N</italic>-(4-methylphenylsulfonyl)-<italic>N</italic>&#x02032;-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes</article-title><source>Biochim Biophys Acta</source><year>1995b</year><volume>1240</volume><fpage>11</fpage><lpage>17</lpage><!--PubMed citation query: 'Biochim Biophys Acta||1240|11||bib20|'--><pub-id pub-id-type="pmid">7495842</pub-id></citation></ref><ref id="bib21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>Chemical hormesis in cell growth: a molecular target at the cell surface</article-title><source>J Appl Toxicol</source><year>2000</year><volume>20</volume><fpage>157</fpage><lpage>163</lpage><!--PubMed citation query: 'J Appl Toxicol||20|157||bib21|'--><pub-id pub-id-type="pmid">10715615</pub-id></citation></ref><ref id="bib22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Bridge</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>LY</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name></person-group><article-title>Preferential inhibition by (&#x02212;)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture</article-title><source>Biochem Pharmacol</source><year>2000</year><volume>60</volume><fpage>937</fpage><lpage>946</lpage><!--PubMed citation query: 'Biochem Pharmacol||60|937||bib22|'--><pub-id pub-id-type="pmid">10974202</pub-id></citation></ref><ref id="bib23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Caldwell</surname><given-names>S</given-names></name><name><surname>Mayorga</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>LY</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name></person-group><article-title>NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients</article-title><source>Arch Biochem Biophys</source><year>1997a</year><volume>342</volume><fpage>224</fpage><lpage>230</lpage><!--PubMed citation query: 'Arch Biochem Biophys||342|224||bib23|'--><pub-id pub-id-type="pmid">9186482</pub-id></citation></ref><ref id="bib24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Chueh</surname><given-names>PJ</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name></person-group><article-title>Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture</article-title><source>Proc Natl Acad Sci USA</source><year>1995c</year><volume>92</volume><fpage>1831</fpage><lpage>1835</lpage><!--PubMed citation query: 'Proc Natl Acad Sci USA||92|1831||bib24|'--></citation></ref><ref id="bib25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Paulik</surname><given-names>M</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Faulk</surname><given-names>WP</given-names></name></person-group><article-title>Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin</article-title><source>J Bioenerg Biomembr</source><year>1997c</year><volume>29</volume><fpage>269</fpage><lpage>280</lpage><!--PubMed citation query: 'J Bioenerg Biomembr||29|269||bib25|'--><pub-id pub-id-type="pmid">9298712</pub-id></citation></ref><ref id="bib26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name></person-group><article-title>Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases</article-title><source>Free Radic Res</source><year>2003</year><volume>37</volume><fpage>795</fpage><lpage>808</lpage><!--PubMed citation query: 'Free Radic Res||37|795||bib26|'--><pub-id pub-id-type="pmid">14567438</pub-id></citation></ref><ref id="bib27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Stevenson</surname><given-names>J</given-names></name><name><surname>Mackellar</surname><given-names>W</given-names></name><name><surname>McClure</surname><given-names>D</given-names></name></person-group><article-title>HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinity</article-title><source>Biochim Biophys Acta</source><year>1995a</year><volume>1244</volume><fpage>133</fpage><lpage>140</lpage><!--PubMed citation query: 'Biochim Biophys Acta||1244|133||bib27|'--><pub-id pub-id-type="pmid">7766649</pub-id></citation></ref><ref id="bib28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Reust</surname><given-names>T</given-names></name></person-group><article-title>A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea <italic>N</italic>-4-(methylphenylsulfonyl)-<italic>N</italic>&#x02032;-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients</article-title><source>J Bioenerg Biomembr</source><year>1997b</year><volume>29</volume><fpage>281</fpage><lpage>289</lpage><!--PubMed citation query: 'J Bioenerg Biomembr||29|281||bib28|'--><pub-id pub-id-type="pmid">9298713</pub-id></citation></ref><ref id="bib29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name><name><surname>Wu</surname><given-names>LY</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name></person-group><article-title>Response of a cell-surface NADH oxidase to the antitumor sulfonylurea <italic>N</italic>-(4-methylphenylsulfonyl)-<italic>N</italic>&#x02032;-(4-chlorophenylurea) (LY181984) modulated by redox</article-title><source>Biochim Biophys Acta</source><year>1998</year><volume>1369</volume><fpage>185</fpage><lpage>192</lpage><!--PubMed citation query: 'Biochim Biophys Acta||1369|185||bib29|'--><pub-id pub-id-type="pmid">9518604</pub-id></citation></ref><ref id="bib30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mosmann</surname><given-names>T</given-names></name></person-group><article-title>Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</article-title><source>J Immunol Methods</source><year>1983</year><volume>65</volume><fpage>55</fpage><lpage>59</lpage><!--PubMed citation query: 'J Immunol Methods||65|55||bib30|'--><pub-id pub-id-type="pmid">6606682</pub-id></citation></ref><ref id="bib31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salucci</surname><given-names>M</given-names></name><name><surname>Stivala</surname><given-names>LA</given-names></name><name><surname>Maiani</surname><given-names>G</given-names></name><name><surname>Bugianesi</surname><given-names>R</given-names></name><name><surname>Vannini</surname><given-names>V</given-names></name></person-group><article-title>Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2)</article-title><source>Br J Cancer</source><year>2002</year><volume>86</volume><fpage>1645</fpage><lpage>1651</lpage><!--PubMed citation query: 'Br J Cancer||86|1645||bib31|'--><pub-id pub-id-type="pmid">12085217</pub-id></citation></ref><ref id="bib32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedlak</surname><given-names>D</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>A drug-unresponsive and protease-resistant CNOX protein from human sera</article-title><source>Arch Biochem Biophys</source><year>2001</year><volume>386</volume><fpage>106</fpage><lpage>116</lpage><!--PubMed citation query: 'Arch Biochem Biophys||386|106||bib32|'--><pub-id pub-id-type="pmid">11360993</pub-id></citation></ref><ref id="bib33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PK</given-names></name><name><surname>Krohn</surname><given-names>RI</given-names></name><name><surname>Hermanson</surname><given-names>GT</given-names></name><name><surname>Mallia</surname><given-names>AK</given-names></name><name><surname>Gartner</surname><given-names>FH</given-names></name><name><surname>Provenzano</surname><given-names>MD</given-names></name><name><surname>Fujimoto</surname><given-names>EK</given-names></name><name><surname>Goeke</surname><given-names>NM</given-names></name><name><surname>Olson</surname><given-names>BJ</given-names></name><name><surname>Klenk</surname><given-names>DC</given-names></name></person-group><article-title>Measurement of protein using bicinchoninic acid</article-title><source>Anal Biochem</source><year>1985</year><volume>150</volume><fpage>76</fpage><lpage>85</lpage><!--PubMed citation query: 'Anal Biochem||150|76||bib33|'--><pub-id pub-id-type="pmid">3843705</pub-id></citation></ref><ref id="bib34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tritton</surname><given-names>RR</given-names></name><name><surname>Yee</surname><given-names>G</given-names></name></person-group><article-title>The anticancer agent adriamycin can be actively cytotoxic without entering cells</article-title><source>Science</source><year>1982</year><volume>217</volume><fpage>248</fpage><lpage>250</lpage><!--PubMed citation query: 'Science||217|248||bib34|'--><pub-id pub-id-type="pmid">7089561</pub-id></citation></ref><ref id="bib35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>R</given-names></name><name><surname>Enc&#x000ed;o</surname><given-names>I</given-names></name><name><surname>Migliaccio</surname><given-names>M</given-names></name><name><surname>Gil</surname><given-names>MJ</given-names></name><name><surname>Mart&#x000ed;nez-Merino</surname><given-names>V</given-names></name></person-group><article-title>Synthesis and cytotoxic activity of lipophilic sulphonamide derivatives of the benzo[<italic>b</italic>]thiophene 1,1-dioxide</article-title><source>Bioorg Med Chem</source><year>2004</year><volume>12</volume><fpage>963</fpage><lpage>968</lpage><!--PubMed citation query: 'Bioorg Med Chem||12|963||bib35|'--><pub-id pub-id-type="pmid">14980609</pub-id></citation></ref><ref id="bib36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DM</given-names></name><name><surname>Morr&#x000e9;</surname><given-names>DJ</given-names></name></person-group><article-title>Sera from cancer patients contain two oscillating ECTO-NOX activities with different period lengths</article-title><source>Cancer Lett</source><year>2003</year><volume>190</volume><fpage>135</fpage><lpage>141</lpage><!--PubMed citation query: 'Cancer Lett||190|135||bib36|'--><pub-id pub-id-type="pmid">12565167</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="fig1"><label>Scheme 1</label><caption><p>i: Acetic acid, H<sub>2</sub>O<sub>2</sub> 30&#x00025; (v&#x02009;v<sup>&#x02212;1</sup>), reflux, 30&#x02009;min; ii: nitric acid 100&#x00025;; iii: Fe/CINH<sub>4</sub>, ethyl alcohol/water 50&#x00025;; iv: NaNO<sub>2</sub>, HCI (ac); SO<sub>2</sub>/CuCl, acetic acid; v: CH<sub>2</sub>Cl<sub>2</sub>; triethylamine.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" mime-subtype="gif" xlink:href="92-6602383f1"/></fig><fig id="fig2"><label>Figure 1</label><caption><p>Structure of BTS used in this work.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" mime-subtype="gif" xlink:href="92-6602383f2"/></fig><fig id="fig3"><label>Figure 2</label><caption><p>Determination of the cytotoxic effect of (<bold>A</bold>) BTS-1 and (<bold>B</bold>) BTS-2. Cells were incubated in the presence of every compound at the indicated concentration for 72&#x02009;h. Cytotoxicity was then determined by a colorimetric microassay based on the use of MTT (<xref ref-type="other" rid="bib30">Mosmann, 1983</xref>). Values represent means&#x000b1;s.d. derived from three independent experiments each performed in quadruplicate.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" mime-subtype="gif" xlink:href="92-6602383f3"/></fig><fig id="fig4"><label>Figure 3</label><caption><p>Dose-dependent inhibition by BTS-2 of NOX activity of (<bold>A</bold>) HeLa cells and (<bold>B</bold>) Cellex preparations in the presence of 100&#x02009;m<sc>M</sc> GSH (solid symbols). Assay was based on spectrophotometric measurement of NADH disappearance at 340&#x02009;nm. The compound was dissolved in ethanol and compared to solvent alone (open symbols).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" mime-subtype="gif" xlink:href="92-6602383f4"/></fig><fig id="fig5"><label>Figure 4</label><caption><p>Lack of inhibition of the NOX activity by BTS-2 under oxidising conditions (solid symbols). (<bold>A</bold>) Normal NOX assays performed with intact HeLa cells in which the preparations were first reduced with 100&#x02009;m<sc>M</sc> GSH for 10&#x02009;min and then fully oxidised by addition of 0.03&#x00025; hydrogen peroxide for 10&#x02009;min. (<bold>B</bold>) As in (<bold>A</bold>) but with 50&#x02009;ml of the Cellex preparation. (<bold>C</bold>) As in (<bold>A</bold>) but with assay in the presence of 100&#x02009;m<sc>M</sc> GSSG. (<bold>D</bold>) As in (<bold>B</bold>) but with assay in the presence of 100&#x02009;m<sc>M</sc> GSSG. The compounds were dissolved in ethanol and compared to solvent alone (open symbols). The ethanol concentration was 0.16&#x00025; maximum.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" mime-subtype="gif" xlink:href="92-6602383f5"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p content-type="table-title">Cytotoxic activities (GI<sub>50</sub>, <italic>&#x003bc;</italic><sc>M</sc> inhibition of cell growth) against tumor cell lines and lipophilicity</p></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"><bold>Compound</bold></th><th align="center" valign="top" char="." charoff="50"><bold>HeLa</bold></th><th align="center" valign="top" char="." charoff="50"><bold>CCRF-CEM</bold></th><th align="center" valign="top" char="." charoff="50"><bold>K-562</bold></th><th align="center" valign="top" char="." charoff="50"><bold>MEL-AC</bold></th><th align="center" valign="top" char="." charoff="50"><bold>HT-29</bold></th><th align="center" valign="top" char="." charoff="50"><bold>HTB-54</bold></th><th align="center" valign="top" char="." charoff="50"><bold>HLF</bold></th><th align="center" valign="top" char="." charoff="50"><bold>log&#x02009;<italic>P</italic></bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">BTS-1</td><td align="char" valign="top" char="." charoff="50">2.2</td><td align="char" valign="top" char="." charoff="50">2.86</td><td align="char" valign="top" char="." charoff="50">29.41</td><td align="char" valign="top" char="." charoff="50">7.14</td><td align="char" valign="top" char="." charoff="50">8.55</td><td align="char" valign="top" char="." charoff="50">5.89</td><td align="char" valign="top" char="." charoff="50">5.04</td><td align="char" valign="top" char="." charoff="50">&#x02212;0.03</td></tr><tr><td align="left" valign="top" charoff="50">BTS-2</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="." charoff="50">0.1</td><td align="char" valign="top" char="." charoff="50">0.07</td><td align="char" valign="top" char="." charoff="50">0.81</td><td align="char" valign="top" char="." charoff="50">2.52</td><td align="char" valign="top" char="." charoff="50">0.23</td><td align="char" valign="top" char="." charoff="50">0.04</td><td align="char" valign="top" char="." charoff="50">2.82</td></tr><tr><td align="left" valign="top" charoff="50">Dx</td><td align="char" valign="top" char="." charoff="50">0.02</td><td align="char" valign="top" char="." charoff="50">0.03</td><td align="char" valign="top" char="." charoff="50">0.02</td><td align="char" valign="top" char="." charoff="50">0.01</td><td align="center" valign="top" char="." charoff="50">ND</td><td align="center" valign="top" char="." charoff="50">ND</td><td align="char" valign="top" char="." charoff="50">0.01</td><td align="center" valign="top" char="." charoff="50">ND</td></tr></tbody></table><table-wrap-foot><fn id="tbfnote1"><label/><p>Dx: doxorubicin; ND: not determined.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article>


